[1]Li J, Li S, Yang L,et al. Severe fever with thrombocytopenia syndrome virus: a highly lethal bunyavirus[J].Crit Rev Microbiol,2021,47(1):112-125.
[2]李昱,杨明,牟笛,等. 2010-2017年全国发热伴血小板减少综合征流行特征分析[J].中国急救复苏与灾害医学杂志,2018,13(11):1076-1079.
[3]姜晓林,丁淑军,逄博,等.山东省发热伴血小板减少综合征实验室确诊病例临床与流行特征分析[J].中国人兽共患病学报,2017,33(12):1077-1081.
[4]Seo JW, KimD,Yun N,et al. Clinical Update of Severe Fever with Thrombocytopenia Syndrome[J].Viruses,2021,13(7):1213.
[5]Tokgoz S, KeskinS,Kayrak M, et al. Is neutrophil/lymphocyteratio predicttoshort-term mortalityin acute cerebralin farctinde pendently from infarctvolume [J]. J Stroke Cerebrovasc Dis, 2014,23(8): 2163-2168.
[6]Yayla C, Akboga MK, Canpolat U, et al. Platelet to Lymphocyte Ratio Can be a Predictor of Infarct-Related Artery Patency in Patients With ST-Segment Elevation Myocardial Infarction[J]. Angiology,2015,66(9):831-836.
[7]Feng JF, Huang Y, Chen QX. Preoperative platelet lymphocyte ratio (PLR) is superior to neutrophil lymphocyte ratio (NLR) as a predictive factor in patients with esophageal squamous cell carcinoma[J]. World J Surg Oncol,2014,12:58. doi: 10.1186/1477-7819-12-58.
[8]Koo CH, Eun Jung D, Park YS, et al. Neutrophil, Lymphocyte, and Platelet Counts and Acute Kidney Injury After Cardiovascular Surgery[J].J Cardiothorac Vasc Anesth,2018,32(1):212-222.
[9]Liu X, Shen Y, Wang H,et al. Prognostic Significance of Neutrophil-to-Lymphocyte Ratio in Patients with Sepsis: A Prospective Observational Study[J].Mediators Inflamm,2016,2016:8191254.doi: 10.1155/2016/8191254.
[10]王刚,吴剑锋. 中性粒细胞与淋巴细胞计数比值、C反应蛋白和降钙素原在重症肺部感染患者中的早期诊断及预后评估价值[J].东南国防医药,2021,23(6):596-599.
[11]Gameiro J, Fonseca JA, Jorge S, et al. Neutrophil, lymphocyte and platelet ratio as a predictor of mortality in septic-acute kidney injury patients[J].Nefrologia (Engl Ed),2020,40(4):461-468.
[12]Cakir Guney B, Hayiroglu M, Senocak D,et al. Evaluation of N/LP Ratio as a Predictor of Disease Progression and Mortality in COVID-19 Patients Admitted to the Intensive Care Unit[J].Medeni Med J,2021,36(3):241-248.
[13]中华人民共和国卫生部.发热伴血小板减少综合征防治指南 (2010版)[J].中华临床感染病杂志,2011,4(4):193-194.
[14]薛宏怡,鲍舟君,竺枫,等. 轻症和重症发热伴血小板减少综合征的血常规及凝血功能差异研究[J].中华实验和临床病毒学杂志,2019,33(3):287-290.
[15]颜莹莹,朱旭辉,胡南南,等. 严重发热伴血小板减少综合征病毒对小鼠巨噬细胞Toll样受体2及炎性因子表达的影响[J].医学研究生学报,2019,32(11):1164-1168.
[16]叶重阳,张荣荣,梅清庭,等. 轻症与重症新型布尼亚病毒感染临床和实验室指标差异分析[J].中国急救复苏与灾害医学杂志,2020,15(7):847-849.
[17]魏艳艳,邹桂舟,叶珺,等. 新型布尼亚病毒感染致发热伴血小板减少综合征临床特点及血常规和血清酶学分析[J].安徽医药,2016,20(5):903-906.
[18]杨旻,叶珺,李惠,等. 69例发热伴血小板减少综合征临床特点及 预后影响因素的调查研究[J].中华疾病控制杂志,2018,22(4):402-405.
[19]Saijo M. Pathophysiology of severe fever with thrombocytopenia syndrome and development of specific antiviral therapy[J].J Infect Chemother,2018,24(10):773-781.